Tart Cherry Juice for Sleep: What the Evidence Shows
A glass of sour cherry juice before bed. It’s the wellness-shelf answer to insomnia that sounds too pleasant to work.
Here’s the honest version. Tart Montmorency cherries genuinely contain melatonin, and a handful of small randomized trials show a real signal: more total sleep, better sleep efficiency, and measurably higher melatonin after drinking a concentrate. But the trials are tiny, short, and heterogeneous, the effect sizes are moderate at best, and the one placebo comparison in insomniacs moved only a single sleep metric. It’s a plausible, low-risk nudge — not a treatment.
Does tart cherry juice actually help you sleep?
The strongest single result comes from a 2018 pilot trial (Losso et al.) in the American Journal of Therapeutics. Adults over 50 with insomnia drank 240 mL of tart cherry juice twice a day for two weeks in a placebo-controlled crossover, with sleep measured by polysomnography — the clinical gold standard, not just a questionnaire.
The eight completers increased their sleep time by 84 minutes on polysomnography (P = 0.0182), and sleep efficiency improved on the Pittsburgh Sleep Quality Index (P = 0.03). Eighty-four minutes is a large, clinically meaningful gain. Keep the scale in mind, though: eight people, two weeks, a crossover design. This is a signal worth chasing, not proof.
What about the placebo comparison?
This is where the honest picture gets more sober — and it’s the part most tart-cherry marketing skips.
A 2010 pilot study (Pigeon et al.) in the Journal of Medicinal Food ran a randomized, double-blind, crossover trial in 15 older adults with chronic insomnia, comparing a tart cherry juice blend against a placebo beverage. Within the cherry-juice arm, sleep improved significantly on every measure from before to after. But that’s the placebo trap: people improve on beverages that taste like a remedy.
When the researchers compared cherry juice against placebo, the drink produced a significant reduction in only one variable — minutes awake after sleep onset. There was no significant advantage over placebo for sleep latency, total sleep time, or sleep efficiency. The authors describe the effect sizes as “moderate and in some cases negligible,” roughly on par with valerian and comparable to some melatonin studies — but “considerably less than those for evidence-based treatments of insomnia: hypnotic agents and cognitive-behavioral therapies.” That last line is the one to remember: cherry juice is not in the same weight class as CBT-I.
How would it even work?
The mechanism is the interesting part, and it’s more than just “cherries have melatonin.”
A 2012 trial (Howatson et al.) in the European Journal of Nutrition gave 20 healthy volunteers a tart cherry concentrate for seven days in a double-blind, placebo-controlled crossover, tracking urinary 6-sulfatoxymelatonin — the main metabolite the body produces from melatonin. Total melatonin content was significantly elevated, and actigraphy plus sleep questionnaires showed improved sleep duration and quality. So the cherries aren’t just a placebo ritual: they measurably raise circulating melatonin, the same hormone your melatonin supplement delivers directly.
There’s a second, less obvious route. In the Losso trial, the cherry procyanidin B-2 inhibited an enzyme called IDO, which normally degrades tryptophan — the amino-acid precursor your body converts into serotonin and then melatonin. By protecting tryptophan and lowering inflammation, the compounds may boost your own melatonin production on top of the small dose you drink. It’s a plausible two-part mechanism, though it rests on one small study and in-vitro cell work.
So why isn’t the evidence stronger?
Because when you pool it, the studies don’t line up neatly.
A 2025 systematic review (Barforoush et al.) in Food Science & Nutrition gathered seven interventional studies of tart cherry and sleep. Three reported significant improvements in sleep duration, efficiency, or onset; three reported higher melatonin levels. But the reviewers flagged “large differences in dose, duration of intervention, and characteristics of the participating populations,” and concluded the evidence is “still limited and heterogeneous.”
That heterogeneity is real. The trials used doses from 30 mL of concentrate to 240 mL of juice twice daily, ran anywhere from a few days to two weeks, and mixed healthy sleepers, insomniacs, and athletes. A result at one dose in one population doesn’t automatically transfer to the bottle on your shelf — and several tart-cherry studies are funded or supplied by the industry that sells it.
So should you drink it?
If you want to try it, the risk profile is about as gentle as it gets: it’s food, the trials report essentially no adverse effects, and unlike a sleeping pill it won’t leave you groggy or raise your fall risk. That’s a low bar to clear for a two-week experiment.
Just size your expectations to the evidence. The realistic case is a modest nudge — a bit more total sleep, slightly less time lying awake — layered on top of the fundamentals, not a fix on its own. Drink an unsweetened Montmorency juice or concentrate in the evening, give it one to two weeks, and judge it by how you actually sleep. And treat it the way you’d treat any natural sleep aid or mineral marketed for rest: a small lever, not the machine. For the bigger picture on a dysregulated nervous system and the tools that actually move sleep, see the pillar guide on anxiety regulation and sleep restoration.